Wed, Jul 23, 2014, 9:07 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Generex Biotechnology Corp. Message Board

  • steveberman49 steveberman49 Jan 31, 2013 3:10 PM Flag

    Yes, Fletcher must go!

    I've had it! My patience is worn out.Fletcher must go! Shame on the Board of Directors for not booting him out by now! Fletcher's lame excuse during the conference call when asked about whether the company should search for a new CEO, replied by saying that it would be difficult to find a qualified candidate with pharma experience to replace him who would be willing to take on the job at this time. Nonsense! Did anyone else also sense the abrupt and unhappy tone by management at the end of the conference call after the question was asked about Fletcher's credibility? They couldn't wait to get off the conference! Either get a qualified CEO to run the company or sell the company to a management team that is capable and experienced in moving a biotech company forward. My gut is that management is pinning its hopes on India approving Oralyn later this year, and that the stock will move up on that news, let's say back to its most recent high of .32...and then implmenting a reverse stock split of 10-to-1 to enabling it to again be listed on the NASQ or American Exchange. Also, if no pharma is interested in buying Antigen right now, is management naive enough to believe that we, as investors and existing shareholders, after all we've been through, will actually be stupid enough to buy new shares of Antigen with the promise of so called "dividends"? It's not enough to have promising products in the pipeline if the CEO has no credibility in the marketplace. I'm also tired of Fletcher repeatedly blaming the past management for all of Generex's problems. That's just a cop out for his incompetence. He's had enough time now to make a difference and he must go, and so should any past or newer Board members whose responsibility is to protect shareholders...not the CEO!

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.0224-0.0004(-1.75%)Jul 23 3:51 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Gilead Sciences Inc.
NasdaqGSWed, Jul 23, 2014 3:59 PM EDT